Category: Treatment
MRA's Latest Research Report: Reaching for the Stars
25 July 2023 In Allies & Partnerships, Events, Melanoma Stories, News, Policy, Prevention, Science, Treatment
Each year, MRA convenes global thought leaders from across the melanoma research community to exchange ideas, report on scientific successes and challenges, and network and forge new collaborations.
Reflecting on a Decade of Progress and Future Heights in Melanoma
21 July 2023 In Allies & Partnerships, News, Science, Treatment
If you told Dr. Jedd Wolchok at the start of his oncology career what melanoma research would look like today, he likely wouldn’t believe you. Wolchok, now a world-renowned medical oncologist and Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, originally faced an alternate...
How Biomarkers Are Used in Melanoma
29 June 2023 In Allies & Partnerships, Events, Prevention, Science, Treatment
The term “biomarker” is a frequent buzz word in cancer care circles, but many patients do not understand what a biomarker is and how they are used in the clinic. At the MRA 2022 Patient Forum, Dr. David Polsky of New York University took away much of the mystery surrounding biomarkers by deftly explaining what they are and how they enter the market, as well as by showing how physicians use biomarkers to guide therapy and predict outcomes in their patients.
Andrew Smith: Father, Veteran, and Melanoma Survivor
By Renee Orcione, MRA Digital Engagement & Communications Manager | 25 June 2023 In Melanoma Stories, Prevention, Treatment
Andrew Smith was 37 years old when his wife Anna noticed an odd-looking spot on his nose and encouraged him to get it checked out. While this father of three wasn’t particularly concerned, he did bring it up with his primary care physician to assure his wife that everything was okay.
Tackling Treatment-Resistant Disease
22 May 2023 In Allies & Partnerships, Events, Science, Treatment
The melanoma field has made incredible progress over the past decade in its ability to treat patients with advanced melanoma. This includes patients with tumors that cannot be entirely removed by surgery and patients whose tumors have spread to other parts of the body, referred to as metastatic melanoma.
MRA Announces $6.3 Million in Grants to Advance Melanoma Prevention, Detection & Treatment
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 1 May 2023 In News, Prevention, Science, Treatment
In recognition of Melanoma Awareness Month and Melanoma Monday, the Melanoma Research Alliance (MRA), announced its new $6.3 million commitment to fund melanoma research, supporting 24 scientists at leading academic and medical institutions across the US and Europe. MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease.
Trust Your Gut & Other Tips for Facing Melanoma
20 April 2023 In Events, Melanoma Stories, Treatment
Whether new to melanoma or well into your journey — as a patient, survivor, or caregiver — practical tips, strategies, and advice were shared at the 2022 MRA Melanoma Exchange Patient and Advocate Forum. Speakers at the Forum discussed what types of providers to seek, how to find information about your disease, how to advocate...
TIL Therapy in Melanoma: Where We Stand
By Tanisha Jackson, PhD - MRA Scientific Program Director | 4 April 2023 In Science, Treatment
Despite the incredible progress made to develop new treatment options for melanoma, almost 50% of patients are still not responding to the latest approved therapies. To address this important unmet need for patients with difficult to treat melanoma, clinicians are looking to new strategies including cellular therapy.
Melanoma Clinical Trials to Watch: March 2023
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 27 March 2023 In News, Science, Treatment
Clinical trials, and the patient volunteers who make them possible, are critical to advancing melanoma research. In the Melanoma Clinical Trials to Watch article series, we’ll regularly highlight clinical trials that are currently recruiting patients, have recently shared exciting updates, or are blazing new trails.
The Role of Targeted Therapy in Treating Advanced Melanoma
By Rachel Fischer, Ph.D., Associate Director, Scientific Program & Registry | 20 March 2023 In Science, Treatment
Targeted therapies are an important part of the melanoma treatment arsenal, but where do they fit within the standard of care? Learn more about BRAF mutations, targeted therapy, and areas of future research.